Leeds Teaching Hospitals NHS Trust

Specialist MDT: Leeds Teaching Hospitals NHS Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Transrectal ultrasound (TRUS) biopsy
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Isotope bone scan
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Low-dose rate brachytherapy
    • High-dose rate brachytherapy
    • Stereotactic body radiation therapy (SBRT)
    • Chemotherapy
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling
    • Genetic counselling

Data Quality

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 325 482
Performance Status recorded 58% 64%
PSA completed 54% 48%
Gleason Score completed N/A N/A
TNM completed 13% 36%
Stage variable assigned 34% 53%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 292 23477
Percentage of men diagnosed with metastatic disease 21% 17%
No. of men diagnosed with M1 (metastases) 60 N/A

Management

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on Gleason score in the Rapid Cancer Registration Dataset

Outcome

Treatment Centre
No. of men who received radical prostatectomy (2020-2021) 46
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 12%
No. of men who received radical prostatectomy (2019) 119
Adjusted percentage of men experiencing at least one GU complication (%) 4%
No. of men who received radical radiotherapy (2019) 576
Adjusted percentage of men experiencing at least one GI complication (%)

Compare provider outcomes